New breath and blood tests could speed up lung disease diagnosis

NCT ID NCT07615504

Recruiting now Diagnosis Sponsor: University of Dundee Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find better, non-invasive tests to diagnose and predict the course of interstitial lung disease (ILD). Researchers will test blood and breath samples from 750 people, including pigeon fanciers at high risk for ILD and patients already diagnosed. The goal is to identify tests that are accurate, easy to use, and acceptable to patients, helping speed up diagnosis and improve care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSTITIAL LUNG DISEASE (ILD)

Contacts and locations

Locations

Ninewells Hospital
RECRUITING

Dundee, DD21UB, United Kingdom
Perth Royal Infirmary
RECRUITING

Perth, PH1 1NX, United Kingdom
Winter Gardens
RECRUITING

Blackpool, FY1 1HU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.